SecBot SecBot
Home › SEC Filings

SEC Filing Analysis

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
CMREPRESS-RELEASEneutral5/10Costamare reported Q3 2026 adjusted EPS of $0.74, above the $0.66 consensus, on voyage revenue of $212.1M (vs. $209.1M cOct 28, 2026
IP8-Kbullish6/10International Paper reported Q3 2026 adjusted operating EPS of $0.37, beating the $0.29 consensus, and revenue of $6.20BOct 28, 2026
DBD8-Kbearish6/10Diebold Nixdorf reported Q3 2026 revenue of $994.3M (up 5.2% YoY) and adjusted EPS of $1.34, slightly above the $1.31 coOct 28, 2026
HSBC6-Kneutral3/10HSBC Holdings plc announced a $1 billion share buy-back program, commencing 29 October 2026 and ending no later than 19 Oct 28, 2026
FNMA8-Kneutral5/10Fannie Mae reported Q3 2026 net income of $4.2 billion, up 5% from $4.0 billion in Q2 2026 and up 8% from $3.9 billion aOct 28, 2026
ENTA8-Kneutral3/10Enanta Pharmaceuticals announced the planned retirement of CEO Jay R. Luly by February 1, 2027, after 23 years, and the Oct 28, 2026
RDWR144neutral3/10Two Radware officers filed Form 144 notices of intent to sell shares on the same day. Riki Goldriech (Officer) plans to Oct 28, 2026
FLEX8-Kbullish6/10Flex reported Q2 FY2027 net sales of $8.5B, up 25% YoY, and record adjusted EPS of $1.18, beating the consensus estimateOct 28, 2026
BLKB8-Kneutral5/10Blackbaud reported Q3 2026 revenue of $292.6M (+4.1% YoY) and non-GAAP EPS of $1.36, above the $1.33 consensus. The compOct 28, 2026
ETSY8-Kbullish5/10Etsy reported Q3 2026 revenue of $692.5M (+10.9% YoY) and GAAP diluted EPS of $1.00 from continuing operations, acceleraOct 28, 2026
RRC425neutral5/10Range Resources filed its Q3 2026 earnings release alongside the pending all-stock acquisition by EQT Corporation. GAAP Oct 28, 2026
LFUS8-Kbullish6/10Littelfuse reported record Q3 2026 net sales of $767M (up 23% reported, 22% organic YoY) and record adjusted diluted EPSOct 28, 2026
VISMSC 13D/Aneutral3/10Paul R. Taylor files this Amendment No. 1 to his Schedule 13D to correct and withdraw his prior filing. He states that tOct 28, 2026
FLEXPRESS-RELEASEbullish6/10Flex reported Q2 FY2027 adjusted EPS of $1.18, beating the $1.06 consensus by 11.3%, and revenue of $8.5B, above the $8.Oct 28, 2026
REPL8-Kneutral5/10Replimune reported fiscal Q2 2027 results with a net loss of $57.1M ($0.54 per share), narrower than the $83.1M loss in Oct 28, 2026
MLYSPRESS-RELEASEbullish6/10Mineralys Therapeutics announced positive Phase 2 Explore-CKD results for lorundrostat, published in Kidney InternationaOct 28, 2026
AMRN8-Kneutral5/10Amarin reported Q3 2026 GAAP net income of $0.2M, its first profitable quarter in over two years, versus a net loss of $Oct 28, 2026
OTLY6-Kneutral5/10Oatly reported Q3 2026 results with revenue of $243.1 million, up 9.1% YoY, and a net loss of $27.5 million, significantOct 28, 2026
QBTS8-Kneutral3/10D-Wave Quantum Inc. announced a non-binding MOU with LG CNS to advance quantum computing adoption for enterprise optimizOct 28, 2026
TEX8-Kbullish6/10Terex reported Q3 2026 adjusted EPS of $1.50, beating the $1.42 consensus by 5.6%, on pro forma revenue growth of 11.6% Oct 28, 2026
AXGN8-Kbullish6/10Axogen reported Q3 2026 revenue of $75.8M (+26.2% YoY), above the $73.2M consensus, and GAAP net income of $2.3M ($0.04 Oct 28, 2026
HAYW8-Kbullish6/10Hayward Holdings reported Q3 fiscal 2026 results with net sales up 6% YoY to $260.1M and adjusted diluted EPS up 29% to Oct 28, 2026
SCLPRESS-RELEASEneutral2/10Stepan Company declared a Q4 2026 quarterly cash dividend of $0.405 per share, a $0.01 increase from the prior quarter, Oct 28, 2026
OTLY6-Kbearish6/10Oatly reported Q3 2026 revenue of $243.1 million (+9.1% YoY), gross margin expansion to 34.1% (+436 bps), and a narrowedOct 28, 2026
DBDPRESS-RELEASEneutral3/10Diebold Nixdorf issued a press release announcing a share buyback program. The release contains no financial results, guOct 28, 2026
GNPX8-Kneutral2/10Genprex announced that research from its sponsored collaboration with Meharry Medical College on the TUSC2 gene therapy Oct 28, 2026
STGSC 13G/Aneutral2/10AREO Holdings Ltd and affiliated Orchid Asia entities filed an amended Schedule 13G for Sunlands Technology Group, disclOct 28, 2026
AEBIPRESS-RELEASEneutral2/10Aebi Schmidt Group announced a quarterly dividend of $0.025 per share and scheduled its Q3 2026 earnings call for NovembOct 28, 2026
QH6-Kneutral2/10Quhuo Limited disclosed that its affiliate, Beijing Quhuo Technology, entered into a credit facility agreement with XiamOct 28, 2026
DDI6-Kneutral2/10DoubleDown Interactive announced it will release Q3 2026 results on November 11, 2026, and host a conference call the saOct 28, 2026
« Previous Page 29 of 334 Next »